scorecardresearch
Saturday, April 27, 2024
TopicRemdesivir

Topic: Remdesivir

Remdesivir trial discovers a Covid weak spot and why this success is critical

In episode 458 of #CutTheClutter, Shekhar Gupta explains the significance of the randomised trial of remdesivir's effectiveness on treating Covid-19.

This is how remdesivir, developed for Hepatitis C and Ebola, fights Covid-19

The experimental antiviral drug that was developed by US pharmaceutical company Gilead Sciences has shown that it leads to faster recovery in Covid-19 patients.

Remdesivir has clear-cut, positive effect on cutting Covid recovery time, says top US doctor

The claims of Dr Anthony Fauci come at the time a study in The Lancet has said ‘remdesivir is not associated with statistically significant clinical benefits’.

Why some experts want more data before they are convinced about remdesivir

Some experts say science has taken a back seat to optimism in the rush to find a way out of the coronavirus crisis that has paralysed economies around the world.

Remdesivir trial shows Covid-19 patients recover faster, could be first effective drug

The US trial looked at whether Gilead’s remdesivir helped people with Covid-19 recover faster than without it.

On Camera

Indira, Manmohan, Modi, all raised income inequality. Until Hindu fears took the driving seat

The issue of inequality has assumed the blazing limelight at a time when inequality in India is said to be higher than it was in the British Raj. It's a ripe situation for half-truths and incendiary statements.

Foreign policy resonating among more Indians in 2nd & 3rd tier towns of India, says EAM Jaishankar

Speaking at launch of economist Surjit Bhalla’s book, S Jaishankar also highlights Gen Z’s engagement with ‘reel culture’, which has 'promoted awareness, created interest in many subjects'.

Germany removes restrictions, India can now buy small arms from its firms

Germany’s erstwhile Christian Democratic Union govt, led by Angela Merkel, prevented sale of small arms to police forces in states they perceived had ‘bad human rights record’.

Frontrunner is letting the challenger define this poll campaign. Modi still hasn’t found a big theme

A theme has not yet emerged for BJP & people see lack of a contest, which makes it unexciting. For all these reasons, 2024 is turning out to be an unexpectedly theme-less election.